Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats

被引:43
作者
Gedulin, BR [1 ]
Young, AA [1 ]
机构
[1] Amylin Pharmaceut, San Diego, CA 92121 USA
关键词
D O I
10.2337/diabetes.47.1.93
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amylin, a 37-amino acid peptide hormone co-secreted with insulin, potently governs the rate of gastric emptying. Hypoglycemia, in the absence of agents such as amylin, is reported to accelerate gastric emptying. We asked whether hypoglycemia had a similar action on gastric emptying in the presence of amylin. In preliminary experiments using a phenol red gavage technique in fasted SD rats, we showed that insulin administration accelerated gastric emptying in a dosage-dependent manner. This acceleration was totally prevented by coadministration of glucose in dosages that prevented a change in plasma glucose, indicating that insulin per se did not affect gastric emptying. The effect on gastric emptying of hypoglycemia induced by a 5 mU/min insulin infusion (t = 5-90 min) was assessed in conscious rats continuously infused with amylin (50 pmol . kg(-1) . min(-1); t = -30 to 90 min). Gastric emptying was indicated by the appearance in plasma of label from 3-O-methyl-[H-3]glucose gavaged at t = 0 min. Label appearance was markedly inhibited in rats preinfused with amylin (84% reduced vs. saline controls at t = 30 min), indicating amylin inhibition of gastric emptying. In amylin-treated rats that were subsequently infused with insulin, gavaged label abruptly appeared in plasma when plasma glucose had fallen to 2.1 +/- 0.1 mmol/l (at t congruent to 45 min), consistent with a reversal by hypoglycemia of amylin's inhibition of gastric emptying. These data support the idea of a central "fail-safe" mechanism whereby hypoglycemia can override the slowing of gastric emptying by amylin.
引用
收藏
页码:93 / 97
页数:5
相关论文
共 28 条
[21]  
THOMPSON R, 1997, DIABETIC MED S2, V14, pA4
[22]  
THOMPSON R, 1997, DIABETES, V40, pA30
[23]   Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM - Results of a multicenter trial [J].
Thompson, RG ;
Peterson, J ;
Gottlieb, A ;
Mullane, J .
DIABETES, 1997, 46 (04) :632-636
[24]   Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake [J].
Young, AA ;
Gedulin, BR ;
Rink, TJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (01) :1-3
[25]  
YOUNG AA, 1995, DIABETOLOGIA, V38, P642, DOI 10.1007/s001250050331
[26]   INSULIN-RESPONSE OF COMPONENTS OF WHOLE-BODY AND MUSCLE CARBOHYDRATE-METABOLISM IN HUMANS [J].
YOUNG, AA ;
BOGARDUS, C ;
STONE, K ;
MOTT, DM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (02) :E231-E236
[27]  
Young AA, 1996, DRUG DEVELOP RES, V37, P231, DOI 10.1002/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.3.CO
[28]  
2-2